Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. MustGrow Biologics's Total Liabilities for the quarter that ended in Mar. 2026 was $1.33 Mil. MustGrow Biologics's Total Assets for the quarter that ended in Mar. 2026 was $2.32 Mil.
Therefore, MustGrow Biologics's Liabilities-to-Assets Ratio for the quarter that ended in Mar. 2026 was 0.57.
Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.
MustGrow Biologics Liabilities-to-Assets Related Terms
MustGrow Biologics Liabilities-to-Assets Historical Data
* Premium members only.
The historical data trend for MustGrow Biologics's Liabilities-to-Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MGROF vs CTVA, CF, MOS: Liabilities-to-Assets Comparison
For the Agricultural Inputs subindustry, MustGrow Biologics's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MustGrow Biologics Liabilities-to-Assets vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, MustGrow Biologics's Liabilities-to-Assets distribution charts can be found below:
* The bar in red indicates where MustGrow Biologics's Liabilities-to-Assets falls into.
Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.
MustGrow Biologics's Liabilities-to-Assets Ratio for the fiscal year that ended in Dec. 2025 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MustGrow Biologics (MGROF) has a Liabilities-to-Assets of 0.57 as of Mar. 2026. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on MustGrow Biologics and its competitors.
Is MustGrow Biologics' Liabilities-to-Assets too high?
MustGrow Biologics' current Liabilities-to-Assets is 0.57. Overall, MustGrow Biologics has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does MustGrow Biologics' Liabilities-to-Assets compare to CTVA and CF?
MustGrow Biologics' Liabilities-to-Assets of 0.57 can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Liabilities-to-Assets for an Agriculture company?
A good Liabilities-to-Assets depends on the Agriculture industry context. However, Liabilities-to-Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Liabilities-to-Assets mean?
A high Liabilities-to-Assets can signal that a stock is expensive relative to its fundamentals. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on MustGrow Biologics and its competitors. MustGrow Biologics's current Liabilities-to-Assets is 0.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MustGrow Biologics stock overvalued right now?
MustGrow Biologics (MGROF) has a current Liabilities-to-Assets of 0.57. The current Liabilities-to-Assets is 0.57. MustGrow Biologics' overall GF Score™ is 24/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Liabilities-to-Assets calculated?
Liabilities-to-Assets is calculated from a company's financial statements. For MustGrow Biologics (MGROF), the current Liabilities-to-Assets is 0.57 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
MustGrow Biologics Corp is a fully integrated provider of biological and regenerative agriculture solutions designed to support sustainable farming. The Company's proprietary and third-party product lines offer eco-friendly alternatives to restricted or banned synthetic chemicals and fertilizers. It offers a portfolio of third-party crop nutrition solutions, including micronutrients, nitrogen stabilizers, biostimulants, and foliar products. These products are synergistically distributed alongside MustGrow's wholly owned proprietary products and technologies that are derived from mustard and developed into organic biocontrol and biofertility products to help replace banned or restricted synthetic chemicals and fertilizers.
24GF Score
Get the complete analysis for MGROF
Liabilities-to-Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MGROF has been successfully added to your 
